In Vivo Effects of Single Intra-Articular Injection of 0.5% Bupivacaine on Articular Cartilage
| Autor: | Constance R. Chu, Venkat Seshadri, Michal Szczodry, Kristina M Cieslak, Elise K Pringle, Charleen T. Chu, Christian H. Coyle, John C. Karpie |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2010 |
| Předmět: |
Cartilage
Articular Male Scientific Articles Knee Joint medicine.drug_class Chirurgie orthopedique Articular cartilage Injections Intra-Articular Rats Sprague-Dawley Intra articular Chondrocytes In vivo Medicine Animals Orthopedics and Sports Medicine Anesthetics Local Bupivacaine Staining and Labeling business.industry Local anesthetic Histological Techniques General Medicine Iodoacetic Acid Rats Anesthesia Toxicity Surgery business Software medicine.drug |
| Popis: | BACKGROUND: Single intra-articular injections of local anesthetics are commonly used clinically. Recent in vitro studies have demonstrated chondrotoxic effects of local anesthetics, with the greatest emphasis on bupivacaine toxicity. This in vivo study was conducted to determine whether a single intra-articular injection of 0.5% bupivacaine results in chondrocyte morbidity and rapid chondrolysis. METHODS: Forty-eight Sprague-Dawley rats received a 100-μL injection of sterile 0.9% saline solution (negative control) into one stifle joint and 100 μL of either preservative-free 0.5% bupivacaine (experimental group) or 0.6 mg/mL monoiodoacetate (positive control) into the contralateral joint. The rats were killed at one week, four weeks, twelve weeks, or six months. Live and dead cells were quantified with use of three-dimensional confocal reconstructions of fluorescent-stained tissues at standardized locations on the distal part of the femur. Histological findings were graded with use of a modified Mankin score, and cell density was quantified with use of custom image-analysis software. RESULTS: In the specimens injected with bupivacaine, the chondral surfaces remained intact as seen with gross and histological examination. No differences in superficial chondrocyte viability or modified Mankin scores were observed between the saline-solution and bupivacaine groups at any location or time point (p > 0.05). Quantitative histological analysis of the bupivacaine-treated knees at six months revealed an up to 50% reduction in chondrocyte density compared with that of the saline-solution-treated knees (p ≤ 0.01). Monoiodoacetate injection resulted in death of up to 87% of the superficial chondrocyte cells at one week and chondrolysis at six months. Despite severe histological abnormalities by four weeks after monoiodoacetate injection, cartilage injury was not evident on gross inspection until six months. CONCLUSIONS: This in vivo study showing reduced chondrocyte density without cartilage tissue loss six months after a single intra-articular injection of 0.5% bupivacaine suggests bupivacaine toxicity. The effects of bupivacaine were milder than those of an injection of 0.6% monoiodoacetate, which resulted in chondrolysis over the same time period. CLINICAL RELEVANCE: This study shows that the in vivo effects of a single injection of intra-articular bupivacaine on articular cartilage are subtle. The data in the monoiodoacetate group show that substantial subsurface pathological effects may not be obvious on gross inspection and suggest that any potential toxic effects of bupivacaine following a single injection would be difficult to detect clinically. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|